Physician profile
Steven W Kreamer
NPI 1124005996
$2,139.26
in general payments reported to CMS, 2019-2025
28 companies · $772 in 2025
The $772 reported for 2025 was more than what 75% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $259 · 2020: $90.68 · 2021: $67.93 · 2022: $309 · 2023: $316 · 2024: $326 · 2025: $772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,413.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $243.69 | 2019-2025 | Stravix, Renasys Go V2 Home, Pico |
| Tactile Systems Technology INC | $243.55 | 2020-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Convatec INC. | $188.37 | 2023-2025 | |
| Averitas Pharma INC. | $181.40 | 2023-2025 | Qutenza |
| Boston Scientific Corporation | $126.81 | 2019-2020 | |
| Kci USA, INC. | $123.44 | 2019-2023 | Promogran Prisma, Activ.A.C. |
| Organogenesis INC. | $110.82 | 2019-2025 | Via Matrix, Affinity |
| Paratek Pharmaceuticals, INC. | $98.21 | 2024-2025 | Nuzyra |
| Grt US Holding, INC. | $77.94 | 2022 | |
| Kerecis Limited | $74.33 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Stryker Corporation | $71.82 | 2023 | Bioskin, Allograft Bio-Implants, Citrefix |
| Vertex Pharmaceuticals Incorporated | $62.69 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $53.37 | 2025 | Exparel |
| Medtronic, INC. | $53.00 | 2025 | Inceptiv |
| Bioventus LLC | $51.17 | 2022-2025 | Exogen Ultrasound Bone Healing System |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $48.97 | 2019-2023 | Cmf |
| Ani Pharmaceuticals, INC. | $48.62 | 2025 | Purified Cortrophin Gel |
| Treace Medical Concepts, INC. | $46.31 | 2025 | |
| Linvatec Corporation | $34.79 | 2019 | |
| Solventum Corporation | $34.58 | 2024 | Activ.A.C. |
| Nabriva Therapeutics, Plc | $32.41 | 2022 | |
| Sanara Medtech INC. | $27.15 | 2022 | |
| Osiris Therapeutics INC. | $23.28 | 2019 | |
| Orthofix Medical, INC. | $21.38 | 2025 | Physio-Stim |
| Depuy Synthes Sales INC. | $17.88 | 2023 | Motoband |
| Acell, INC. | $17.57 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $13.01 | 2023 | Seglentis |
| Merck Sharp & Dohme LLC | $12.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Kreamer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.